A one-of-a-kind way to screen
for colon cancer at home
Thanks for tuning in to the Wiser Than Me podcast and coming here to learn more about Cologuard.
Regular screening is recommended beginning at age 45 for people at average risk according to the American Center Society.
Cologuard is the first and only FDA approved non-invasive screening test that looks for both altered DNA and blood in your stool.
Cologuard in noninvasive - no prep, no time off and no changes to diet or medication.
Most insured patients pay $0*.
Cologuard is intended to screen adults 45 years of age and older who are at average risk for colorectal cancer by detecting certain DNA markers and blood in the stool. Do not use if you have had adenomas, have inflammatory bowel disease and certain hereditary syndromes, or a personal or family history of colorectal cancer. Cologuard is not a replacement for colonoscopy in high risk patients. Cologuard performance in adults ages 45-49 is estimated based on a large clinical study of patients 50 and older. Cologuard performance in repeat testing has not been evaluated.
The Cologuard test result should be interpreted with caution. A positive test result does not confirm the presence of cancer. Patients with a positive test result should be referred for colonoscopy. A negative test result does not confirm the absence of cancer. Patients with a negative test result should discuss with their doctor when they need to be tested again. False positives and false negative results can occur. In a clinical study, 13% of people without cancer received a positive result (false positive) and 8% of people with cancer received a negative result (false negative). Rx only.